Home Information & Technology Artificial Intelligence Artificial Intelligence (AI) in Life Sciences Market

Artificial Intelligence (AI) in Life Sciences Market Size, Share & Trends Analysis Report By Technology (Machine Learning, Deep Learning, Natural Language Processing, Others), By Application (Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision & Personalized Medicine, Others), By Drug Type (Small Molecule, Large Molecule), By Offering (Software, Services), By Indication (Immuno-Oncology, Neurodegenerative Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Pavan Warade | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Artificial Intelligence (AI) in Life Sciences Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Machine Learning (ML)
    2. Deep Learning (DL)
    3. Natural Language Processing (NLP)
    4. Others
  2. Artificial Intelligence (AI) in Life Sciences Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Drug Discovery
    2. Medical Diagnosis
    3. Biotechnology
    4. Clinical Trials
    5. Precision and Personalized Medicine
    6. Patient Monitoring
    7. Novel Drug Candidates
    8. Drug Optimization and Repurposing Preclinical Testing and Approval
    9. Drug Monitoring
    10.  Finding New Diseases Associated Targets and Pathways
    11.  Understanding Disease Mechanisms
    12.  Aggregating and Synthesizing Information
    13.  Formation & Qualification of Hypotheses
    14.  De Novo Drug Design
    15.  Finding Drug Targets of an Old Drug
  3. Artificial Intelligence (AI) in Life Sciences Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Small Molecule
    2. Large Molecule
  4. Artificial Intelligence (AI) in Life Sciences Market, By Offering 2022-2034 (USD MILLION/ Units)
    1. Software
    2. Services
  5. Artificial Intelligence (AI) in Life Sciences Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Immuno-Oncology
    2. Neurodegenerative Diseases
    3. Cardiovascular Diseases
    4. Metabolic Diseases
    5. Others
  6. Artificial Intelligence (AI) in Life Sciences Market, By End user 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical & Biotechnology Companies
    2. Contract Research Organizations (CROs)
    3. Research Centres And Academic Institutes
    4. Others
  7. Regional Artificial Intelligence (AI) in Life Sciences Market
    1. North America
      1. North America Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. North America Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. North America Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. North America Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. North America Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. North America Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. U.S.
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      8. Canada
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
    2. Europe
      1. Europe Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. Europe Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. Europe Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. Europe Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. Europe Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. Europe Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. U.K.
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      8. Germany
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      9. France
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      10. Spain
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      11. Italy
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      12. Russia
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      13. Nordic
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      14. Benelux
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      15. Rest of Europe
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
    3. APAC
      1. APAC Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. APAC Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. APAC Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. APAC Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. APAC Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. APAC Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. China
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      8. Korea
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      9. Japan
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      10. India
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      11. Australia
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      12. Taiwan
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      13. South East Asia
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      14. Rest of Asia-Pacific
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
    4. Middle East and Africa
      1. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. Middle East and Africa Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. UAE
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      8. Turkey
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      9. Saudi Arabia
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      10. South Africa
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      11. Egypt
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      12. Nigeria
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      13. Rest of MEA
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
    5. LATAM
      1. LATAM Artificial Intelligence (AI) in Life Sciences Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
      2. LATAM Artificial Intelligence (AI) in Life Sciences Market By Application 2022-2034 (USD MILLION/ Units)
        1. Drug Discovery
        2. Medical Diagnosis
        3. Biotechnology
        4. Clinical Trials
        5. Precision and Personalized Medicine
        6. Patient Monitoring
        7. Novel Drug Candidates
        8. Drug Optimization and Repurposing Preclinical Testing and Approval
        9. Drug Monitoring
        10.  Finding New Diseases Associated Targets and Pathways
        11.  Understanding Disease Mechanisms
        12.  Aggregating and Synthesizing Information
        13.  Formation & Qualification of Hypotheses
        14.  De Novo Drug Design
        15.  Finding Drug Targets of an Old Drug
      3. LATAM Artificial Intelligence (AI) in Life Sciences Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Small Molecule
        2. Large Molecule
      4. LATAM Artificial Intelligence (AI) in Life Sciences Market By Offering 2022-2034 (USD MILLION/ Units)
        1. Software
        2. Services
      5. LATAM Artificial Intelligence (AI) in Life Sciences Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Immuno-Oncology
        2. Neurodegenerative Diseases
        3. Cardiovascular Diseases
        4. Metabolic Diseases
        5. Others
      6. LATAM Artificial Intelligence (AI) in Life Sciences Market By End user 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical & Biotechnology Companies
        2. Contract Research Organizations (CROs)
        3. Research Centres And Academic Institutes
        4. Others
      7. Brazil
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      8. Mexico
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      9. Argentina
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      10. Chile
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      11. Colombia
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
      12. Rest of LATAM
        1. Machine Learning (ML)
        2. Deep Learning (DL)
        3. Natural Language Processing (NLP)
        4. Others
        5. Drug Discovery
        6. Medical Diagnosis
        7. Biotechnology
        8. Clinical Trials
        9. Precision and Personalized Medicine
        10. Patient Monitoring
        11. Novel Drug Candidates
        12. Drug Optimization and Repurposing Preclinical Testing and Approval
        13. Drug Monitoring
        14.  Finding New Diseases Associated Targets and Pathways
        15.  Understanding Disease Mechanisms
        16.  Aggregating and Synthesizing Information
        17.  Formation & Qualification of Hypotheses
        18.  De Novo Drug Design
        19.  Finding Drug Targets of an Old Drug
        20. Small Molecule
        21. Large Molecule
        22. Software
        23. Services
        24. Immuno-Oncology
        25. Neurodegenerative Diseases
        26. Cardiovascular Diseases
        27. Metabolic Diseases
        28. Others
        29. Pharmaceutical & Biotechnology Companies
        30. Contract Research Organizations (CROs)
        31. Research Centres And Academic Institutes
        32. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.